The Promising Effect of Tocilizumab on Chronic Antibody-Mediated Rejection (cAMR) of Kidney Transplant.

Pharmaceutics · 2025 · PMC11768637 · PMID 39861726

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

marginally insignificantp = 0.053so close (0.05 < p ≤ 0.1)

1.1 ± 0.8 at baseline, and was found to be marginally insignificant ( p = 0.053) [ 17 ].

also in 137 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.